Identification of a G(2) arrest domain in the E1 wedge E4 protein of human papillomavirus type 16.
Human papillomavirus type 16 (HPV16) is the most common cause of cervical carcinoma. Cervical cancer develops from low-grade lesions that support the productive stages of the virus life cycle. The 16E1 wedge E4 protein is abundantly expressed in such lesions and can be detected in cells supporting vegetative viral genome amplification. Using an inducible mammalian expression system, we have shown that 16E1 wedge E4 arrests HeLa cervical epithelial cells in G(2). 16E1 wedge E4 also caused a G(2) arrest in SiHa, Saos-2 and Saccharomyces pombe cells and, as with HeLa cells, was found in the cytoplasm. However, whereas 16E1 wedge E4 is found on the keratin networks in HeLa and SiHa cells, in Saos-2 and S. pombe cells that lack keratins, 16E1 wedge E4 had a punctate distribution. Mutagenesis studies revealed a proline-rich region between amino acids 17 and 45 of 16E1 wedge E4 to be important for arrest. This region, which we have termed the "arrest domain," contains a putative nuclear localization signal, a cyclin-binding motif, and a single cyclin-dependent kinase (Cdk) phosphorylation site. A single point mutation in the putative Cdk phosphorylation site (T23A) abolished 16E1 wedge E4-mediated G(2) arrest. Arrest did not involve proteins regulating the phosphorylation state of Cdc2 and does not appear to involve the activation of the DNA damage or incomplete replication checkpoint. G(2) arrest was also mediated by the E1 wedge E4 protein of HPV11, a low-risk mucosal HPV type that also causes cervical lesions. The E1 wedge E4 protein of HPV1, which is more distantly related to that of HPV16, did not cause G(2) arrest. We conclude that, like other papillomavirus proteins, 16E1 wedge E4 affects cell cycle progression and that it targets a conserved component of the cell cycle machinery.
Davy
Clare E
CE
Division of Virology, National Institute for Medical Research, London NW7 1AA.
Jackson
Deborah J
DJ
Wang
Qian
Q
Raj
Kenneth
K
Masterson
Phillip J
PJ
Fenner
Nicola F
NF
Southern
Shirley
S
Cuthill
Scott
S
Millar
Jonathan B A
JB
Doorbar
John
J
D000595:Amino Acid Sequence; D001665:Binding Sites; D018797:Cell Cycle Proteins; D004261:DNA Replication; D016195:G2 Phase; D006367:HeLa Cells; D006801:Humans; D008969:Molecular Sequence Data; D009687:Nuclear Proteins; D015514:Oncogene Proteins, Fusion / Q000737:chemistry* / Q000502:physiology*; D010766:Phosphorylation; D011505:Protein-Tyrosine Kinases / Q000502:physiology; D029702:Schizosaccharomyces pombe Proteins; D013329:Structure-Activity Relationship; D014764:Viral Proteins; D020687:cdc25 Phosphatases / Q000502:physiology
D018797:Cell Cycle Proteins; D009687:Nuclear Proteins; D015514:Oncogene Proteins, Fusion; D029702:Schizosaccharomyces pombe Proteins; D014764:Viral Proteins; C072777:oncogene protein E1--E4, Human papillomavirus type 16; C090679:mik1 protein, S pombe; C068689:wee1 protein, S pombe; D011505:Protein-Tyrosine Kinases; C499349:WEE1 protein, human; D020687:cdc25 Phosphatases